ASX Announcements

December 2009 Road-Show and Fund Manager Presentation

11 Dec 2009

Leading Australia-based medical-devices company, Compumedics Limited (ASX: CMP) is pleased to provide the attached presentation currently being used in meetings with fund managers, brokers and analysts.

Click here to download the presentation (PDF 3.94 MB) 

For Further information:

Mr David Burton    
Executive Chairman, CEO   
Phone: + 61 3 8420 7300     
Fax: +61 3 8420 7399   

Mr David Lawson
Chief Financial Officer
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399

Investor Relations & Media Enquires:

Mr Rod North
Managing Director
Bourse Communications Pty Ltd
Phone: +61 3 9510 8309
Mobile: +61 (0) 408 670 706

About Compumedics

Compumedics Limited, founded in 1987, is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology.

In 1987 Compumedics established Asia Pacific’s first fully computerised sleep laboratory.  Compumedics holds 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological, and Doppler blood-flow diagnostic monitoring devices.

In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia and offices in the United States, and Europe the products are distributed in over 50 countries.

In 1998 Compumedics was awarded the overall Australian Exporter of the Year.

In 2000 Compumedics was listed on the Australian Stock Exchange.

In 2002 Compumedics acquired US-based Neuroscan - the world's leading supplier of instruments for brain-research.  In the US - the world's largest medical device market - Neuroscan holds around 90% of the market for brain-research products. 

In 2003 Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy.

In 2004 Compumedics acquired German-based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-vascular diagnostic fields.

In 2006 Compumedics was awarded the Frost and Sullivan Technology Leadership award for the innovative Somté recorder product.

In 2007 Compumedics and Chairman were inducted into the Victorian Manufacturing Hall of Fame.

In 2008 the DWL division received the top 100 German Innovation award.  With 20,000 systems installed globally across the finest hospital, universities and clinics the Compumedics sales have grown more than 4 fold from $9 million (1999) to $39 million (2008).

In 2009 Compumedics was awarded a design award for its Grael™ PSG/EEG premium laboratory based product.

Visit : www.compumedics.com for more information

Back